Table 3. Comparison of individual MACE events between patients with and without CMD.
All patients N=610 | CMD– N=340 | CMD+ N=270 | p-value | |
Composite MACE, n (%) | 174 (29) | 83 (24) | 91 (34) | 0.01 |
Death, n (%) | 96 (16) | 45 (13) | 51 (19) | 0.06 |
Myocardial infarction, n (%) | 35 (6) | 17 (5) | 18 (7) | 0.38 |
Revascularisation, n (%) | 38 (6) | 19 (6) | 19 (7) | 0.46 |
Stroke, n (%) | 30 (5) | 14 (4) | 16 (6) | 0.31 |
CFR: coronary flow reserve; HMR: hyperaemic microvascular resistance; MACE: major adverse cardiovascular events |